TERN
NASDAQStockTerns Pharmaceuticals, Inc.
$44.24-2.54 (-5.43%)
52-Week Range
$2.00
$47.09
Key Stats
Market Cap
4.0B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.29
Volume
1.6M
Avg Volume
2.0M
Performance
1M
+15.84%
3M
-1.69%
6M
+520.48%
YTD
+10.30%
1Y
+1108.74%
3Y
+372.15%
5Y
+78.03%
Price Chart
ETF Exposure
TERN is held by 70 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| VTI | Vanguard Total Stock Market ETF | 0.01% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
PreviousPage 2 of 2
About TERN ETF Exposure
Terns Pharmaceuticals, Inc. (TERN) is held by 70 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.0B, TERN is a widely held institutional stock. The stock currently trades at $44.24. Investors can gain exposure to TERN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TERN, sorted by portfolio weight.